当前位置: 首页 >> 检索结果
101. Computer-aided Detection of Polyps Does Not Improve Colonoscopist Performance in a Pragmatic Implementation Trial.
作者: Uri Ladabaum.;John Shepard.;Yingjie Weng.;Manisha Desai.;Sara J Singer.;Ajitha Mannalithara.
来源: Gastroenterology. 2023年164卷3期481-483.e6页 102. Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study.
作者: Kefang Sun.;Yishu Chen.;Zhenzhen Wang.;Yi Liu.;Yue Pan.;Xinli Mao.;Lei Xu.;Chaohui Jin.;Ming Chen.;Chaohui Yu.;Lan Li.
来源: BMC Gastroenterol. 2022年22卷1期520页
To improve the eradication rate of H. pylori, researchers have investigated the role of WeChat-based mini-app as an electronic reminding system in H. pylori treatment.
103. Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy.
作者: Jian-Xu Li.;Mei-Ling He.;Mo-Qin Qiu.;Liu-Ying Yan.;Mei-Ying Long.;Jian-Hong Zhong.;Rui-Jun Zhang.;Chun-Feng Liang.;Ya-Dan Pang.;Jun-Kun He.;Qian-Qian Chen.;Jin-Xia Weng.;Shi-Xiong Liang.;Bang-De Xiang.
来源: BMC Gastroenterol. 2022年22卷1期510页
For patients with unresectable hepatocellular carcinoma (uHCC), intensity-modulated radiotherapy (IMRT) has become one of the options for clinical local treatment. Immune parameters, including platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and systemic immune inflammatory (SII), predict survival in various cancers. This study aimed to determine whether peripheral immune parameters can predict survival in patients with uHCC undergoing IMRT and establish a clinically useful prognostic nomogram for survival prediction.
104. Change lifestyle modification plan/transtheoretical model in non-alcoholic simple fatty liver disease: a pilot randomized study.
Non-alcoholic simple fatty liver disease patients have very low compliance with almost all types of physical activities. A transtheoretical model-oriented lifestyle modification plan awakens the patient's consciousness in the pre-intention stage. Aim to evaluate whether a management by stages of change plan based on the Transtheoretical Model and Stages of Change promoted behavior change for patients with non-alcoholic simple fatty liver disease.
105. Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study.
作者: Kathrine Aglen Seeberg.;Dag Hofsø.;Heidi Borgeraas.;John Olav Grimnes.;Farhat Fatima.;Lars Thomas Seeberg.;Nils Petter Kvan.;Marius Svanevik.;Jens Kristoffer Hertel.;Jøran Hjelmesæth.
来源: BMC Gastroenterol. 2022年22卷1期448页
Obesity, non-alcoholic fatty liver disease (NAFLD) and insulin resistance are three pathological conditions highly correlated, but this relationship is not fully elucidated. Hence, we aimed to assess the association of hepatic steatosis and fibrosis with different measures of insulin sensitivity in patients with severe obesity and type 2 diabetes mellitus (T2DM).
106. An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding.
作者: Hsueh-Chien Chiang.;Er-Hsiang Yang.;Huang-Ming Hu.;Wei-Ying Chen.;Wei-Lun Chang.;Chung-Tai Wu.;Deng-Chyang Wu.;Bor-Shyang Sheu.;Hsiu-Chi Cheng.
来源: BMC Gastroenterol. 2022年22卷1期439页
Patients with Rockall scores ≥6 have an increased risk of long-term peptic ulcer rebleeding. This study was aimed toward investigating whether an extended course of oral esomeprazole up to 1 year decreased ulcer rebleeding in such patients.
107. Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial.
作者: Loren Laine.;Kenneth DeVault.;Philip Katz.;Stefan Mitev.;John Lowe.;Barbara Hunt.;Stuart Spechler.
来源: Gastroenterology. 2023年164卷1期61-71页
For decades, proton pump inhibitors (PPIs) have been the mainstay of treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan provides more potent acid inhibition than PPIs, but data on its efficacy for erosive esophagitis are limited.
108. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
作者: C Fiorella Murillo Perez.;Holly Fisher.;Shaun Hiu.;Dorcas Kareithi.;Femi Adekunle.;Tracy Mayne.;Elizabeth Malecha.;Erik Ness.;Adriaan J van der Meer.;Willem J Lammers.;Palak J Trivedi.;Pier Maria Battezzati.;Frederik Nevens.;Kris V Kowdley.;Tony Bruns.;Nora Cazzagon.;Annarosa Floreani.;Andrew L Mason.;Albert Parés.;Maria-Carlota Londoño.;Pietro Invernizzi.;Marco Carbone.;Ana Lleo.;Marlyn J Mayo.;George N Dalekos.;Nikolaos K Gatselis.;Douglas Thorburn.;Xavier Verhelst.;Aliya Gulamhusein.;Harry L A Janssen.;Rachel Smith.;Steve Flack.;Victoria Mulcahy.;Michael Trauner.;Christopher L Bowlus.;Keith D Lindor.;Christophe Corpechot.;David Jones.;George Mells.;Gideon M Hirschfield.;James Wason.;Bettina E Hansen.; .
来源: Gastroenterology. 2022年163卷6期1630-1642.e3页
The Primary Biliary Cholangitis (PBC) Obeticholic Acid (OCA) International Study of Efficacy (POISE) randomized, double-blind, placebo-controlled trial demonstrated that OCA reduced biomarkers associated with adverse clinical outcomes (ie, alkaline phosphatase, bilirubin, aspartate aminotransferase, and alanine aminotransferase) in patients with PBC. The objective of this study was to evaluate time to first occurrence of liver transplantation or death in patients with OCA in the POISE trial and open-label extension vs comparable non-OCA-treated external controls.
109. Bowel preparation using 2-L split-dose polyethylene glycol regimen plus lubiprostone versus 4-L split-dose polyethylene glycol regimen: a randomized controlled trial.
作者: Apichet Sirinawasatien.;Pallop Sakulthongthawin.;Kanokpoj Chanpiwat.;Tanyaporn Chantarojanasiri.
来源: BMC Gastroenterol. 2022年22卷1期424页
Colonoscopy is a standard procedure for evaluating colon diseases and screening for colorectal cancer, and bowel cleanliness prior to colonoscopy is key. The aim of this study was to compare the bowel cleansing efficacy of low-volume (2 L) split-dose polyethylene glycol (PEG) plus single-dose (24 µg) lubiprostone (LB) and high-volume (4 L) split-dose PEG.
110. Transient alterations in plasma sodium concentrations with NER1006 bowel preparation: an analysis of three phase III, randomized clinical trials.
This analysis characterized changes in sodium levels in patients receiving the 1 L polyethylene glycol-based preparation NER1006.
111. Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial.
作者: Yongtong Zhan.;Shuqing Liang.;Zecheng Yang.;Qichen Luo.;Shuai Li.;Jiamin Li.;Zhaojia Liang.;Yalan Li.
来源: BMC Gastroenterol. 2022年22卷1期391页
Painless gastrointestinal endoscopy is widely used for the diagnosis and treatment of digestive diseases. At present, propofol is commonly used to perform painless gastrointestinal endoscopy, but the high dose of propofol often leads to a higher incidence of cardiovascular and respiratory complications. Studies have shown that the application of propofol combined with ketamine in painless gastrointestinal endoscopy is beneficial to reduce the dosage of propofol and the incidence of related complications. Esketamine is dextrorotatory structure of ketamine with a twice as great anesthetic effect as normal ketamine but fewer side effects. We hypothesized that esketamine may reduce the consumption of propofol and to investigate the safety of coadministration during gastrointestinal endoscopy.
112. Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
作者: Baili Chen.;Jie Zhong.;Xiuling Li.;Feng Pan.;Yijuan Ding.;Yan Zhang.;Hong Chen.;Fei Liu.;Zhenyu Zhang.;Ling Zhang.;Rafal Drozda.;Oleksandr Oliinyk.;Aik Han Goh.;Xiang Chen.;Xiang Sun.;David T Rubin.;William J Sandborn.;Minhu Chen.
来源: Gastroenterology. 2022年163卷6期1555-1568页
Current therapies for ulcerative colitis (UC) fail to achieve satisfactory disease control. Selective inhibition of Janus kinase (JAK) type 1 may improve clinical outcomes in patients with UC while avoiding the side effects associated with pan-JAK inhibition. The safety and efficacy of the selective JAK1 inhibitor ivarmacitinib (formerly SHR0302) were evaluated in patients with moderate-to-severe, active UC.
113. Comparison of anal dilatation versus no dilatation with a standardized dilator in reducing pain after hemorrhoidectomy: a randomized control trial.
作者: Imam Sofii.;Handy Darmawan.;Amelia Sophia Ramadhini.;Fauzan Kurniawan.;Ahmad Shafa Hanif.
来源: BMC Gastroenterol. 2022年22卷1期379页
Post-operative pain is the main problem of hemorrhoidectomy. An adequate pain management can promote early mobilization, fast recovery, and reduce hospitalization costs. This study aimed to investigate the role of preoperative anal dilatation using a standardized anal dilator in reducing post-operative pain.
114. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial.
作者: Marie Truyens.;Triana Lobatón.;Marc Ferrante.;Peter Bossuyt.;Séverine Vermeire.;Lieven Pouillon.;Pieter Dewint.;Anneline Cremer.;Harald Peeters.;Guy Lambrecht.;Edouard Louis.;Jean-François Rahier.;Olivier Dewit.;Vinciane Muls.;Tom Holvoet.;Liv Vandermeulen.;Anneleen Peeters.;Gerard Bryan Gonzales.;Simon Bos.;Debby Laukens.;Martine De Vos.
来源: Gastroenterology. 2022年163卷5期1294-1305.e3页
Fatigue is highly prevalent among patients with inflammatory bowel disease (IBD), and only limited treatment options are available. Based on the hypothetical link between low serum tryptophan concentrations and fatigue, we determined the effect of 5-hydroxytryptophan supplementation on fatigue in patients with inactive IBD.
115. Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge.
作者: Joseph A Murray.;Jack A Syage.;Tsung-Teh Wu.;Matthew A Dickason.;Ana G Ramos.;Carol Van Dyke.;Irina Horwath.;Philip T Lavin.;Markku Mäki.;Isabel Hujoel.;Konstantinos A Papadakis.;Adam C Bledsoe.;Chaitan Khosla.;Jennifer A Sealey-Voyksner.; .
来源: Gastroenterology. 2022年163卷6期1510-1521.e6页
Gluten ingestion in patients with celiac disease can lead to gastrointestinal symptoms and small intestinal mucosal injury.
116. Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease.
Eccentric exhaustive exercise (EEE) training has been known as a promising training modality to enhance performance and stimulate adaptation in healthy individuals or patients that might also cause abnormal liver enzymes and lipid profiles. Vitamin D (Vit D) supplementation is believed to improve the condition of Non-Alcoholic Fatty Liver Disease (NAFLD) patients. However, there is limited evidence on the effect of Vit D supplementation on the EEE-induced alterations. This study aimed to investigate the effect of short-term supplementation of Vit D on the liver enzymes and lipid profile alterations following EEE in overweight women with NAFLD.
117. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
作者: Motonobu Hamazaki.;Tsunaki Sawada.;Takeshi Yamamura.;Keiko Maeda.;Yasuyuki Mizutani.;Eri Ishikawa.;Satoshi Furune.;Kenta Yamamoto.;Takuya Ishikawa.;Naomi Kakushima.;Kazuhiro Furukawa.;Eizaburo Ohno.;Takashi Honda.;Hiroki Kawashima.;Masatoshi Ishigami.;Masanao Nakamura.;Mitsuhiro Fujishiro.
来源: BMC Gastroenterol. 2022年22卷1期342页
Fecal microbiota transplantation (FMT) is a potential treatment for irritable bowel syndrome (IBS), but its efficacy in Japanese IBS patients is unknown. This study aimed to evaluate the efficacy, side effects, and microbiome changes following FMT in Japanese IBS patients.
118. Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications.
作者: Sachin Wani.;Rhonda F Souza.;Valerie L Durkalski.;Jose Serrano.;Frank Hamilton.;Nicholas J Shaheen.; .
来源: Gastroenterology. 2022年163卷3期556-562.e4页 119. Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.
作者: William D Chey.;Francis Mégraud.;Loren Laine.;Luis J López.;Barbara J Hunt.;Colin W Howden.
来源: Gastroenterology. 2022年163卷3期608-619页
Novel, effective treatments for Helicobacter pylori infection are needed. This study evaluated the efficacy of vonoprazan, a potassium-competitive acid blocker, vs standard treatment on H pylori eradication in the United States and Europe.
120. Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.
作者: Mohammed Ghiboub.;Susanne Penny.;Charlotte M Verburgt.;Rotem Sigall Boneh.;Eytan Wine.;Alejandro Cohen.;Katherine A Dunn.;Devanand M Pinto.;Marc A Benninga.;Wouter J de Jonge.;Arie Levine.;Johan E Van Limbergen.
来源: Gastroenterology. 2022年163卷4期922-936.e15页
The Crohn's disease (CD) exclusion diet (CDED) plus partial enteral nutrition (PEN) and exclusive enteral nutrition (EEN) both induce remission in pediatric CD. CDED+PEN is better tolerated and able to sustain remission. We characterized the changes in fecal metabolites induced by CDED+PEN and EEN and their relationship with remission.
|